YU55998A - Oral or implant pharmaceutical formulation with controlled release - Google Patents

Oral or implant pharmaceutical formulation with controlled release

Info

Publication number
YU55998A
YU55998A YU55998A YU55998A YU55998A YU 55998 A YU55998 A YU 55998A YU 55998 A YU55998 A YU 55998A YU 55998 A YU55998 A YU 55998A YU 55998 A YU55998 A YU 55998A
Authority
YU
Yugoslavia
Prior art keywords
oral
controlled release
pharmaceutical formulation
implant
implant pharmaceutical
Prior art date
Application number
YU55998A
Other languages
English (en)
Serbo-Croatian (sh)
Serbian (sr)
Inventor
C Nay John Leeper
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of YU55998A publication Critical patent/YU55998A/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
YU55998A 1996-06-06 1998-12-04 Oral or implant pharmaceutical formulation with controlled release YU55998A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65946396A 1996-06-06 1996-06-06

Publications (1)

Publication Number Publication Date
YU55998A true YU55998A (en) 1999-11-22

Family

ID=24645503

Family Applications (1)

Application Number Title Priority Date Filing Date
YU55998A YU55998A (en) 1996-06-06 1998-12-04 Oral or implant pharmaceutical formulation with controlled release

Country Status (17)

Country Link
EP (1) EP0914128A1 (fr)
JP (1) JP2000511906A (fr)
KR (1) KR20000016406A (fr)
CN (1) CN1226166A (fr)
AU (1) AU3233197A (fr)
BR (1) BR9709546A (fr)
CA (1) CA2256720A1 (fr)
CZ (1) CZ397698A3 (fr)
EA (1) EA199900006A1 (fr)
HU (1) HUP0003885A2 (fr)
IL (1) IL126966A0 (fr)
NO (1) NO985695L (fr)
PL (1) PL330637A1 (fr)
TR (1) TR199802496T2 (fr)
WO (1) WO1997046241A1 (fr)
YU (1) YU55998A (fr)
ZA (1) ZA974978B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19815411A1 (de) * 1998-04-06 1999-10-07 Solvay Pharm Gmbh Thermogenese stimulierend wirksame Arzneimittel
WO2000044355A1 (fr) * 1999-01-29 2000-08-03 Eli Lilly And Company Sels de moxonidine
ES2235829T3 (es) * 1999-02-01 2005-07-16 Solvay Pharmaceuticals Gmbh Utilizacion de moxonidina para el tratamiento post-infarto de corazon.
EP1894927B1 (fr) * 2006-08-31 2010-11-10 Chemagis Ltd. Utilisation des sels de moxonidine pour la purification de monoxidine
KR100812287B1 (ko) * 2007-01-03 2008-03-13 주식회사 챠콜코리아 내면에 반사층을 갖는 신호등 갓

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4323570A (en) * 1978-11-15 1982-04-06 Beiersdorf Aktiengesellschaft Substituted aminopyrimidines
DE3617158C2 (de) * 1986-05-22 1994-10-06 Lohmann Therapie Syst Lts Transdermales Arzneimittel
DE3729299A1 (de) * 1987-09-02 1989-03-23 Beiersdorf Ag Transdermales therapeutisches system
DE3904795C2 (de) * 1989-02-17 2000-10-12 Lilly Pharma Produktion Gmbh & Pharmazeutisches Präparat und dessen Verwendung
DE4325491A1 (de) * 1993-07-29 1995-02-02 Boehringer Ingelheim Kg Verwendung von zentral wirksamen alpha-2-Agonisten zur Hemmung des Postaggressionsstoffwechsels
DE4423177A1 (de) * 1994-07-01 1996-01-04 Kali Chemie Pharma Gmbh Antihyperglykämisch wirksame Arzneimittel
CA2182851A1 (fr) * 1995-08-15 1997-02-16 August Masaru Watanabe Methode de traitement d'un etat resultant de l'arret de la consommation abusive de drogues

Also Published As

Publication number Publication date
NO985695L (no) 1999-02-04
AU3233197A (en) 1998-01-05
WO1997046241A1 (fr) 1997-12-11
TR199802496T2 (xx) 1999-02-22
CZ397698A3 (cs) 1999-05-12
PL330637A1 (en) 1999-05-24
EA199900006A1 (ru) 1999-06-24
EP0914128A1 (fr) 1999-05-12
ZA974978B (en) 1998-12-07
HUP0003885A2 (hu) 2001-04-28
KR20000016406A (ko) 2000-03-25
JP2000511906A (ja) 2000-09-12
CN1226166A (zh) 1999-08-18
BR9709546A (pt) 1999-08-10
IL126966A0 (en) 1999-09-22
NO985695D0 (no) 1998-12-04
CA2256720A1 (fr) 1997-12-11

Similar Documents

Publication Publication Date Title
SE9901973D0 (sv) Implantat för applicering i ben och förfarande och användning vid sådant implantat
DK0671957T3 (da) Fremgangsmåde til behandling af et kirurgisk implanat af metal
DE3877174D1 (de) Bezugssystem zur implantation von kondylaeren knie-totalprothesen.
EP0678285A3 (fr) Implant orthopédique et procédé pour le fabriquer.
TR199802441A3 (tr) Kanda asiri ürik asit bulunmasinin tedavisi ve önlenmesi için yöntem ve terkip.
FI964332A (fi) Eräiden metaanibisfosfonihappojohdannaisten käyttö proteesin löystymisen ja proteesin vaelluksen estämiseen
ZA984463B (en) Fused dihydropyrans
ITBO920452A0 (it) "metodo per la realizzazione di protesi da implantologia e dispositivoper l'attuazione di tale metodo".
DE69919179D1 (de) Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen
EP0793660A4 (fr) 1,1-dioxydes de 1,2,5-thiadiazolidin-3-one substitues en position 2, compositions et procede d'utilisation
DE69814394D1 (de) Verwendung von levobupivacain
DE3852389D1 (de) Rissformungsverhütung in implantierten Prothesen.
YU55998A (en) Oral or implant pharmaceutical formulation with controlled release
DE69626816D1 (de) Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
UA50761C2 (uk) Спосіб запобігання та/або лікування серцевих захворювань, фармацевтична композиція та спосіб запобігання та/або лікування серцевої недостатності та дисфункції шлуночків в організмі теплокровної тварини
HK1002658A1 (en) Imidazopyridine-azolidinones their preparation and pharmaceutical use
ITBO970245A0 (it) Dispositivo e metodo di ancoraggio per l'impianto di stents biforcati.
DE69734349D1 (de) Behandlung von knochenleiden mit adrenomedullin
MX9704035A (es) 1,1-dioxidos de 2-(fosfiniloximetil)-1,2,5-tiadiazolidin-3-ona substituidos y composiciones y metodo de uso de los mismos.
MX9704036A (es) 1,1-dioxidos y composiciones de 2-(2,3,5,6-tetrafluoro-4-piridil)-1,2,5-thiadizaolidin-3-ona y metodo de uso.
SE9500897D0 (sv) The pharmacological use of certain cystine derivatives
MXPA01008247A (es) Composicion dental formdora de pelicula resistente al acido y metodo de uso de la misma.
EE04951B1 (et) R-(+)-alfa-(2,3-dimetoksfenl)-1-[2-(4-fluorofenl)etl]-4-piperidiinmetanooli kasutamine uneh„irete raviks
ITRM940240A0 (it) Impianto endosseo e presa di finitura per moncone protesico.
IT1279984B1 (it) Armatura per la realizzazione di implantoprotesi dentarie, rimovibili, in particolare provvisorie